Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
moving on the right track, we can expect some good news in the next couple of week in regards to the bill in congress pass in Jan and more exciting news, this is another article i just found:
https://cannabisnow.com/hemp-cbd-unaffected-dea-rescheduling-panic/
Can you read chart?!
Take a look at this short report!!!!!
http://otcshortreport.com/?index=ACOL&action=view
Bill Submitted on Jan 27 2017
H.R. 331—Filed by Rep. Barbara Lee (D-CA), the States' Medical Marijuana Rights Protection Act would block federal civil asset forfeiture aimed at the owners of state-legal medical marijuana operations.
H.R. 714—Filed by Rep. H. Morgan Griffith (R-VA), the Legitimate Use of Medicinal Marihuana Act would move marijuana to the Controlled Substance Act's Schedule II, opening the door to more research and, potentially, doctors' ability to prescribe (as opposed to recommend) marijuana for patients. It would also bar the use of that act or the Food, Drug, and Cosmetic Act to interfere with medical marijuana in states where it is legal.
H.R. 715—Also filed by Rep. Griffith, the Compassionate Access Act would reschedule marijuana, provide for its medical use under state laws, and remove CBD (cannabidiol) from the definition of marijuana.
H.R. 975—Filed by Cannabis Caucus co-chair Rep. Rohrabacher, the Respect State Marijuana Laws Act would exempt people and entities from certain provisions of the Controlled Substances Act if they are acting in compliance with state laws. Rohrabacher authored similar legislation in the last Congress, garnering 20 cosponsors, including seven Republicans.
chart is prime for a run to an easy 0.0030 by monday!
:) good entries, but i never buy in the morning, my best buys happen after or during lunch hrs
Thanks for the info! im ready to pull the trigger sometime tomorrow
Simple Moving Average 10,20,30 is 85,84,84 though i think it can move in the rage of 0.0070 - 0.0080 for the most day depending on how many people will unload, but best time to buy is mid day, and definitely not end of the day, nor next monday
chart is attached
http://ih.advfn.com/p.php?pid=chartscreenshot&u=tJGQw4QlMoMzzUdtYSpSBDyetx9uka33nd%2FM1KvZGGI%3D&kslash=s
im drawing my chart right now and i will post it but, yes its around there, and when i mean major is because if im into at least 2 millions at 0.0090 its 18 k vs 12-14k :)
This stock is really nice, though is due for a major pull back shortly, back i will definitely buy into the dips and add more, right after it can easily run into pennies, but its too hot
Just as an updated Barchart has raised the opinion from 42% on Monday to 64% today, im not saying this is going fast but solid base yesterday at 0.0009 and today adding a new leg up with new investors (the usually wait to see if the prior base was broken down to new lows and that was not the case, that means less shorter, since its riskier, more longs with real capital injection)
im long here!
Chart is consolidating, is getting ready to break out, support is strong, short term should be 0.0012-0.0013
http://ih.advfn.com/p.php?pid=chartscreenshot&u=vcvtYdPBC7gvfYq6EqXCceb%2FvQoK1szc1E5xKp%2Fw6uk%3D&kslash=s
just as end of the day Twitter Talk on ACOL (Medtainer)
https://twitter.com/WallStPanther/with_replies
I agree with you all, but we remember earlier in Jan and even in Dec 2016 the ACOL moves to 0070 then back down 0040 area, then goes even lower to the 0023 range, then with news (REAL F*CKING NEWS) goes back up and maintain the trend.
We hit 0.052 a few days ago and i dare to shorters play part as well as real investors, it may retrace to whatever level, and yes it is a OTC stock, but check the twitter trend guys, check the correlation of the upcoming bill in congress to remove CBD (not marijuana complete) from schedule 1 (already submitted around Jan 20-Jan 21, financials coming up, recored sales in January, CANADA is getting ready to explote in recreational marijuana, which is not the USA sales but geezzz its a lot,
A link to an Organigram response from a Twitter User
Asked #Organigram about the @themedtainer $ACOL pic.twitter.com/AmgmX2T1cS
— Drake (@WallStPanther) January 27, 2017
News on The Industry - Acology Included
Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry
Tue Feb 07 08:30:00 2017 EDT
PALM BEACH, Florida, February 7, 2017 /PRNewswire via COMTEX News Network/ --
The injection of modern technology into the developing world of cannabis and
legal medical marijuana is helping the industry climb to new heights and increase
engagement with consumers, especially when it comes to cannabis patients in the
medical facet of the industry. The synergy created between modern technology and
the explosive cannabis industry is allowing leaders in marijuana to leverage consumer
technology engagement for companies such as Reliq Health Technologies Inc. (OTC:
RQHTF) (TSX-V: RHT), Acology Inc. (OTC: ACOL), Cannabis Science, Inc. (OTC: CBIS),
Lifestyle Delivery Systems Inc (OTC: LDSYF) and mCig, Inc., (OTC: MCIG) Reliq Health Technologies Inc. (OTCQB: RQHTF) (RHT.V), is pleased to announce
that it has entered into a Memorandum of Understanding (MOU) with Invictus MD Strategies
Corp. (IMH.V on the CSE exchange and also trading on the OTC Markets under the symbol:
IVITF;) ("Invictus MD") to develop a mobile application for cannabis patients and
consumers and their clinical care teams. Reliq Health, a healthcare technology company
focused on developing innovative mobile health and telemedicine solutions, has developed
a novel SaaS (software as a service) solution for the community health care market.
The solution provides automated remote patient monitoring in the home and secure
cloud-based communication, care planning and collaboration for all members of the
patient's circle of care. Reliq's secure platform allows clinicians to collect comprehensive
data on patients' clinical conditions, medication usage, symptoms, side effects
and behaviours - creating a wealth of population health data. Read this full release
and recent news releases for Reliq Health Technologies at http://marketnewsupdates.com/news/rqhtf.html. "Studies consistently show that providing patients with the tools they need
for self-management of their health conditions produces better health outcomes and
reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions
including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple
sclerosis and post-traumatic stress disorder. Our cannabis app allows patients to
track usage and record symptoms specific to their clinical condition, allowing patients
and their care providers to determine optimum strain, dosing and mode of administration.
Our platform will improve access to care by connecting patients with physicians
in their community who have experience with medical marijuana, and supports physician-approved
automated prescription refills through participating producers," said Dr. Lisa Crossley,
CEO of Reliq. Invictus MD's Chairman and CEO, Dan Kriznic, said, "Our wholly owned subsidiary:
Poda Technologies Ltd. ("Poda") is set for a launch in Q2 2017 of its Poda Pod vaporizer
product which will provide an effective, reliable and convenient way to vaporize
cannabis that is designed to appeal to modern retail and medical consumers." The
Poda Pod vaporizer product, made with medical-grade components, has been designed
to connect to users' smartphones via Bluetooth to provide real-time information
about dosage, product characteristics, track remaining contents, find vendors nearby,
and customize their experience. Agreements are being negotiated to license the PODA
products to the Access to Cannabis for Medical Purposes Regulations ("ACMPR") and
licensed producers in Canada, helping those producers better reach and serve consumers
with convenient, refillable devices. In other cannabis and medical marijuana sector related performance and announcements
in markets of note: Acology Inc. (OTC: ACOL) closed up over 13% on Monday trading big volume
of over 77.8 Million shares by the market close. Acology announced on Monday that
January was the biggest sales month in company history, shattering previous marks
achieved during the last quarter of 2016. Acology executives have expressed strong
confidence that the first quarter of 2017 would continue this trend, basing their
optimism on continued expansion in Canada and the addition of new, complimentary
products and product lines. Company income rose 33% above the same period last year.
Unit sales of all products, led by Acology's signature product, the MedTainer(TM),
increased by 25% over last year. Cannabis Science, Inc. (OTC: CBIS) closed up slightly on Monday trading over
21.8 Million shares by the market close. Cannabis Science, together with its subsidiaries,
develops, produces, and commercializes phyto cannabinoid-based pharmaceutical products
primarily in the United States. The company is involved in developing medicines
for autism, blood pressure, cancer and cancer side effects, as well as for other
illnesses comprising for general health maintenance. Lifestyle Delivery Systems Inc (OTCQB: LDSYF) closed up over 12% at $0.5752
on Monday trading over 800,000 shares by the market close. Lifestyle Delivery Systems
produces and sells cannabis infused strips. It develops and licenses a proprietary
filmstrip technology that can be used to produce oral delivery systems for energy
elixirs, herbal remedies, and a smokeless alternative option to medical and recreational
users of cannabis mCig, Inc., (OTCQB: MCIG), a diversified company servicing the legal cannabis,
hemp, and CBD markets announced on Monday its preliminary earnings and financial
results for its third quarter for FY 2017, ending January 31, 2017. MCIG generated
$1.3M in revenue through its construction, CBD, and e-Cig divisions during the third
quarter bringing its total revenue for the FY to $2.2M. The revenue generated represents
a 546% increase from the same period last year, and a 204% increase from last quarter.
MCIG's net income for the quarter was $898K (with a $118K adjusted net income) bringing
its total net income YTD to $716K ($227K adjusted net income), a 32% net margin.
The company generated $341K in cash from operations and has increased its cash,
and cash equivalents, position by 311% this fiscal year to $420K. MCIG reports $1.26M
in current assets with only $287K in current liabilities giving it an acid test
ratio of 4.3:1, its highest rating in company history. DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news
dissemination service provider, which disseminates electronic information through
multiple online media channels. MNU is NOT affiliated in any manner with any company
mentioned herein. MNU and its affiliated companies are a news dissemination solutions
provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market
updates, news alerts and corporate profiles are NOT a solicitation or recommendation
to buy, sell or hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due diligence on their own
and consult a licensed financial professional before considering any level of investing
in stocks. All material included herein is republished content and details which
were previously disseminated by the companies mentioned in this release. MNU is
not liable for any investment decisions by its readers or subscribers. Investors
are cautioned that they may lose all or a portion of their investment when investing
in stocks. For current services performed MNU has been compensated three thousand
nine hundred dollars for news coverage of the current press release issued by Reliq
Health Technologies Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF
ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. "Forward-looking statements" describe future expectations, plans, results,
or strategies and are generally preceded by words such as "may", "future", "plan"
or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually"
or "projected". You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking statements, including
the risks that actual results may differ materially from those projected in the
forward-looking statements as a result of various factors, and other risks identified
in a company's annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission. You should consider these factors
in evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and MNU undertakes no obligation to update such statements. Contact Information:
Media Contact email:
info@marketnewsupdates.com
+1(561)325-8757 SOURCE MarketNewsUpdates.com https://rt.prnewswire.com/rt.gif?NewsItemId=enUK201702071066&;Transmission_Id=201702070830PR_NEWS_USPR_____enUK201702071066&DateId=20170207
Copyright (C) 2017 PR Newswire. All rights reserved
SID(PRN038p6572)
ACOL CBIS LDSYF MCIG PNCRD RHT-AC RHT-CC RHT-VC RQHTF
BUSINESS FINANCE HEALTHCARE PHARMACEUTICALS PUBCO+CANADA PUBCO+SELECT PUBLIC+COMPANIES WALL+STREET bc-MarketNewsUpdates.com csta+stories financenews financenews+select hedge+funds iapws prn
**CS-H-10
The Effect "FDA" is a very strong one, this is got momentum and will cary on for some time today we close at 0.0027 - 0.0032
GAP UP TO 0.0018 HUGE!!!! GET READY!
Thanks! you are right!
i know, i saw it today but its not posted on the board on the top, like usual, the latest news here is from Dec 2016
The News should have been posted here by ihub i think
**** UPDATE YOUTUBE VIDEO ON ACOLOGY AND THE MEDTAINER
Just out today on Twitter: https://twitter.com/MobileWrapsCA/status/827629819428995077
DeelTrades @KyleDeel interesting comments - Watch
https://www.periscope.tv/KyleDeel/1mrGmNPRkZQJy
can anyone recommend a good L2 software ? im on a mac
Guys, simply put your sell order higher at $1.50 or even $2 i wont say i will buy more but i assure you i wont sell any untill its a lot higher
Tomorrow is a fresh start, we should head back to mids 40's and take it from there
This could be seen as a healthy pull back, it happens on any stocks where its shorted, but look as we speak realtime is showing 0.038 and is coming back up right away, also keep in mind this company has a real business running pending on major deals, 0.07 should be our next set target short term
i have a feeling i may hit that mark first and based on their numbers, financials and traders sentiments it can move right after, they already have 3 great products on the markets and it is a matter of time when this stock moves ver fast
How do you know they own them. Just curious since I have a few shares here I would love to know more. Thanks!
VPOR is a stock with products, the reason this can be down is USMJ and ALKM are flying today and a lot of moneys are being moved towards those tickers since they are moving fast, i just got a few more millions here i know it has what it takes to at least record 0.05 in 5-7 months.
CBD is getting re scheduled soon and this is going to fly right after
News Out VPOR can easily be the next ACOL with real products and $$$$
http://marijuanastocks.com/cannabidiol-oil-will-not-be-affected-by-dea-rescheduling/
I agree with you
I'm not selling any. I have large POSITIONS in ERBB MCOA USMJ PURA and a few others including ACOL and I will give up any other of my stocks and just keep ACOL in fact this is the one that is keeping g the book balanced with a large profit
We should be in another day at a 17-20% increment in pps. Sellers should put their ask higher as we move into the day
How is the pre market looking at this point?
CANADA IS GEARING UP AND SETTING THE FRAMEWORK
CANNABIS CANADA OFICIAL WEBSITE
http://cann-can.ca/
A FRAMEWORK FOR THE LEGALIZATION AND REGULATION OF CANNABIS IN CANADA THE FINAL REPORT OF THE TASK FORCE ON CANNABIS LEGALIZATION AND REGULATION Government of Canada
http://cann-can.ca/wp-content/uploads/2016/12/Task-Force-report-Dec-2016.pdf
Another Estate just Went Legal Today
https://www.yahoo.com/news/latest-marijuana-implementation-committee-start-soon-180850567.html
there is no need to sell if you are smart, unless you are looking for pocket change
L2 Please